Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ascites × Zoledronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 54 Prostatic Neoplasms 43 Neoplasm Metastasis 24 Multiple Myeloma 24 Osteoporosis 14 Pain 13 Carcinoma, Non-Small-Cell Lung 9 Neoplasms 8 Osteosarcoma 7 Lung Neoplasms 7 Carcinoma, Renal Cell 6 Neuroblastoma 5 Neoplasms, Plasma Cell 5 Humoral Hypercalcemia Of Malignancy 5 Fractures, Bone 4 Bone Diseases, Metabolic 4 Sarcoma, Ewing 3 Sarcoma 3 Lymphoma 3 Kidney Neoplasms 3 Bone Neoplasms 3 Bone Diseases 3 Uterine Cervical Neoplasms 2 Spinal Cord Compression 2 Small Cell Lung Carcinoma 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Ovarian Neoplasms 2 Osteonecrosis 2

Interventions

sintilimab 1 danvatirsen 1 catumaxomab 1 aflibercept 1 Zoledronic Acid 1 Quality of Life 1 Portasystemic Shunt, Transjugular Intrahepatic 1 Octreotide 1 Nutritional Status 1 Interviews as Topic 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06759064 2025-11-19

IPIZA

Qilu Hospital of Shandong University

Phase 1/2 Recruiting

Gastrointestinal

Adenocarcinoma, Ascites, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡